Home31R • FRA
Follow
Revive Therapeutics Ltd
Previous close
€0.015
Day range
€0.015 - €0.015
Year range
€0.0054 - €0.064
Market cap
8.72M CAD
Avg Volume
3.61K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
(CAD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 784.33K | -48.85% |
Net income | -770.62K | 49.47% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -784.25K | 48.85% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 708.42K | -0.25% |
Total assets | 12.88M | -6.99% |
Total liabilities | 3.35M | -22.75% |
Total equity | 9.53M | — |
Shares outstanding | 358.45M | — |
Price to book | 0.51 | — |
Return on assets | -14.71% | — |
Return on capital | -19.47% | — |
Cash Flow
Net change in cash
(CAD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -770.62K | 49.47% |
Cash from operations | -883.42K | -0.81% |
Cash from investing | — | — |
Cash from financing | 0.00 | — |
Net change in cash | -883.42K | -0.81% |
Free cash flow | -612.49K | -89.40% |
About
Founded
2012
Headquarters
Website
Employees
2